Nanotechnology For Sensitive Detection Of The Carcinoembryonic Antigen: A Cancer Biomarker
Share This:
                           

About The Author

Dr. Minhaz Uddin Ahmed is a Senior Assistant Professor of Analytical Chemistry and Biotechnology at the Universiti Brunei Darussalam (UBD). He obtained his Ph.D. in Chemical Materials Science from Japan Advanced Institute of Science and Technology (JAIST) in 2008 under the supervision of Prof. Eiichi Tamiya and later worked as a JSPS post-doctoral fellow at Osaka University, Japan (2008-2009, with Prof. Eiichi Tamiya); DARPA post-doctoral research associate at Duke University, US (2009-2010, with Prof. April S. Brown); and NSERC post-doctoral fellow at INRS-EMT, Canada (2010-2012, with Prof. M. Zourob). His research interests are in the areas of biosensors and diagnostic technologies as well as applications to nanobiotechnology and clinical and environmental chemistry. Dr Ahmed is an alumnus of JAIST and a prestigious young participant/fellow of the 57th Lindau Nobel Laureate Meeting for Physiology and Medicine in Germany in 2007. In 2008, he was awarded with the prestigious Japanese Society for the Promotion of Science (JSPS) young scientist award to work in the Graduate School of Engineering of Osaka University. In 2009, he was awarded with the United States Defence Advanced Research Project Agency (DARPA) post-doctoral fellowship to work at the Pratt School of Engineering at Duke University. Currently, Dr Ahmed also serving as one of the Associate Editors of the journal “RSC Advances” published by the Royal Society of Chemistry (RSC), UK.

                       

Nanotechnology For Sensitive Detection Of The Carcinoembryonic Antigen: A Cancer Biomarker

The carcinoembryonic antigen (CEA) is one of the most important clinical cancer biomarkers.  It is reported that an increase in the concentration of CEA in adult plasma may be an early indication of a number of cancerous diseases, including colon tumors, breast tumors, ovarian carcinoma, colorectal cancer, and cystadenocarcinoma. Since raised levels of plasma CEA may signify the presence of cancer and an indication of a possible disease, early detection of CEA, albeit at low concentrations, is an important step...

Read more